IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B HBSAG SERUM LEVELS EARLY DURING TREATMENT WITH PEGINTERFERON ALFA-2A PREDICT HBSAG CLEARANCE 4 YEARS POST-TREATMENT

被引：0

作者：

Marcellin, Patrick ^{[1
,2
]}

Brunetto, Maurizia ^{[3
]}

Bonino, Ferruccio ^{[4
]}

Hadziyannis, Stephanos J. ^{[5
]}

Kapprell, Hans-Peter ^{[6
]}

McCloud, Philip I. ^{[7
]}

Batrla, Richard ^{[8
]}

机构：

[1] Hop Beaujon, Serv Hepatol, Clichy, France

[2] Hop Beaujon, INSERM, CRB3, Clichy, France

[3] Azienda Osped Univ Pisana, UO Epatol, Pisa, Italy

[4] Policlin Milano, Direz Sci, Columbia, MO USA

[5] Henry Dunant Hosp, Athens, Greece

[6] Abbot GmbH & Co, Wiesbaden, Germany

[7] Roche Prod Pty Ltd, Dee Why, NSW, Australia

[8] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

919

引用

页码：718A / 719A

页数：2